In addition to humoral responses, cellular immunity contributes to protection against COVID-19 and recent evidence suggests that viral-vector and mRNA vaccines elicit long-lasting S-specific or nucleoprotein-specific CD4+ and CD8+ T cell responses, with broad cross-reactivity against VOCs29,30. Here, CD8A is linked to COVID-19.